Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
3(50.0%)
Phase 1
3(50.0%)
6Total
Phase 2(3)
Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03052842Phase 2Completed

A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application

Role: collaborator

NCT03000348Phase 2Completed

A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations

Role: collaborator

NCT03620110Completed

A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test

Role: collaborator

NCT02594254Phase 2Completed

Phase 2 Study to Evaluate the Microbiology and Safety of C16G2 Administered to Adult and Adolescent Dental Subjects

Role: collaborator

NCT03279120Phase 1Completed

Safety, PK, and PD Study of IVRs Releasing TFV and LNG

Role: collaborator

NCT02904369Phase 1Completed

PK and PD Study of Oral F/TAF for HIV Prevention

Role: collaborator

NCT02722343Phase 1Completed

Exploratory Pharmacodynamic Study of Tenofovir-Based Products

Role: collaborator

All 7 trials loaded